Taeniasis clinical trials
The registry lists 27 studies for Taeniasis across 9 countries. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 18
- Withdrawn
- 3
- Terminated
- 3
- Not yet recruiting
- 2
- Recruiting
- 1
Phase
- Phase 3
- 7
- Phase 1
- 4
- Phase 2
- 3
- Phase 4
- 1
Where
- Peru
- 7
- United States
- 6
- Zambia
- 3
- Tanzania
- 3
- Ecuador
- 2
- India
- 1
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (6) · Technical University of Munich (3) · Universidad Peruana Cayetano Heredia (3) · Oregon Health and Science University (2) · All India Institute of Medical Sciences, New Delhi (2) · National Institute of Mental Health (NIMH) (2) · University of Oslo (1) · Institute of Tropical Medicine, Belgium (1)
Studies
Recruiting first, then most recently updated. Showing 27 of 27 — search for more.
- Natural History of Treated Neurocysticercosis and Long-Term OutcomesRecruitingNCT000012051 country
- Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal NeurocysticercosisNot yet recruitingNCT06376396Phase 4
- Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based StudyNot yet recruitingNCT04706819
- Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)TerminatedNCT02945527Phase 2/31 country
- Treatment of Patients With Active Neurocysticercosis in Eastern AfricaCompletedNCT038343371 country
- Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of ZambiaCompletedNCT038746891 country
- The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural TanzaniaCompletedNCT038514191 country
- Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?CompletedNCT02612896Not applicable1 country
- Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)TerminatedNCT02947581Phase 31 country
- SANCC: Clinical Trial Early InterventionWithdrawnNCT03950037Phase 2
- Two Cases of Pulmonary Cysticercosis Manifesting as Pleural Effusion: Case Report and Literature ReviewCompletedNCT05010811
- Digital Health Promotion in Iringa, TanzaniaCompletedNCT03808597Not applicable1 country
- Phase I Trial Evaluating the Safety and Pharmacokinetics of OxfendazoleCompletedNCT02234570Phase 11 country
- PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28CompletedNCT00526916Phase 11 country
- RCT ALB for SA CysticercosisWithdrawnNCT00133458Phase 34 countries
- PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FBCompletedNCT00527579Phase 11 country
- People Presenting With Neurocysticercosis in North AmericaTerminatedNCT022338551 country
- EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina FasoCompletedNCT03095339Not applicable1 country
- Brain Tissue Swelling and Seizure Activity in Inactive CysticercosisCompletedNCT000019122 countries
- Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis PatientsCompletedNCT00290823Phase 31 country
- Single Ascending Dose Safety Study of OxfendazoleWithdrawnNCT01584362Phase 1
- Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CTCompletedNCT02243644Phase 31 country
- Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)CompletedNCT00441285Phase 2/31 country
- Randomized Study of Albendazole in Patients With Epilepsy Due to NeurocysticercosisCompletedNCT00004403Not applicable
- Taenia Solium Control Case Study in ZambiaCompletedNCT01368354Not applicable1 country
- Targeted Screening for Taenia Solium TapewormsCompletedNCT01296958Not applicable1 country
- A Pilot Study of Neurocysticercosis TreatmentCompletedNCT00283699Phase 31 country